Fate Therapeutics Inc. (FATE)
Market Closed
1 Sep, 20:00
$
2. 43
+0.04
+1.6736%
After Hours
$
+0.17 +6.9959% 2. 60
278.58M Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
-1.96 Eps
$ 2.39
Previous Close 
Want to track FATE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fate Therapeutics Inc. (FATE) Statistics
Valuation metrics
Market Cap 278.58M
Enterprise value 326.48M
Trailing P/E (ttm) -2.31
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) 43.64
Price/Book (mrq) 1.91
Enterprise Value/Revenue 50.3
Enterprise Value/EBITDA -2.79
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 709.8K
Average volume (90 days) 3.66M
Price summary
52-Week low 0.93
52-Week high 3.23
Beta -
50-Day moving average 2.51
200-Day moving average 1.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -19.41%
Operating margin -20.58%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.49
Current ratio (mrq) 4.85%
Book value per share (mrq) 1.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
